Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Uterine Cervical Neoplasms × Eflornithine × 1 year × Clear all

Sponsor

Conditions

Neuroblastoma 6 Sarcoma, Ewing 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive 2 Medulloblastoma 2 Typical Teratoid Rhabdoid Tumor 1 Rhabdoid Tumor 1 Prostatic Neoplasms 1 Osteosarcoma Recurrent 1 Melanoma 1 Lung Neoplasms 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

pembrolizumab 31 Cisplatin 28 Carboplatin 15 Radiotherapy 14 Paclitaxel 14 Bevacizumab 14 Brachytherapy 13 Colposcopy 11 Specimen Handling 10 Nivolumab 10 Blood Specimen Collection 10 Gemcitabine 9 Radiation 8 Magnetic Resonance Spectroscopy 8 Human Papillomavirus DNA Tests 8 Drug Therapy 8 lenvatinib 6 atezolizumab 6 Platinum 6 dostarlimab 5 Radiotherapy, Intensity-Modulated 5 Methods 5 Biopsy 5 1,2-diaminocyclohexaneplatinum II citrate 5 zimberelimab 4 toripalimab 4 spartalizumab 4 Topotecan 4 Restraint, Physical 4 Pemetrexed 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡